Other functions - efficacy of aspirin and naproxen (short-term-frequent dosing) in colorectal cancer models
Ended Awarded Last action
- Contract number
- HHSN26100002
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $770,768
Award facts
- Contract value 100% obligated
- $770,757.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Close Out | -$11 | |
| Modification | $770,768 | |
| Other Administrative Action | $0 |
About this award
This is a federal delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Oklahoma (OU) for "OTHER FUNCTIONS - EFFICACY OF ASPIRIN AND NAPROXEN (SHORT-TERM-FREQUENT DOSING) IN COLORECTAL CANCER MODELS". The $770,757.36 contract is a cost-no-fee award that is part of the Preclinical Agent Development Assays 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The work is focused on preclinical in vitro and in vivo agent development assays. This contract did not utilize a small business set-aside. OU, a public research university, has a history of providing medical research, healthcare, and education services to federal agencies through prime contracts, subcontracts, and grants.
Quick answers
Who was awarded contract HHSN26100002?
HHSN26100002 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100002 worth?
The government has obligated $770,768 on HHSN26100002. Its current value, with exercised options, is $770,757.
Is contract HHSN26100002 an order under another contract?
Yes. HHSN26100002 is a delivery order under HHSN261201200020I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100002 competed?
The extent of competition for HHSN26100002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award